Skip to content

Impact of COVID-19 on working style and daily life of Japanese adult with AD/HD-like symptoms

Impact of COVID-19 on working style and daily life of Japanese adult with AD/HD-like symptoms - Impact of COVID-19 on working style and daily life of Japanese adult with AD/HD-like symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043532
Enrollment
2000
Registered
2021-03-05
Start date
2021-03-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AD/HD

Interventions

None listed

Sponsors

SHIONOGI & CO., LTD.
Lead Sponsor
Takeda Pharmaceutical Company Limited.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Participants registered with Medilead Healthcare Panel (MHP) who have answers at the survey on December 2019 (past survey) 2. Participants with any kind of work at the time of past survey 3. Participants of aged 20 or over at the time of past survey 4. Participants who did not report a hospital visit due to AD/HD within a year of the time of past survey

Exclusion criteria

Exclusion criteria: Participants who work at hospital, clinic or pharmacies.

Design outcomes

Primary

MeasureTime frame
Unemployment rate PHQ-9 WPAI EQ-5D

Countries

Japan

Contacts

Public ContactYoshikazu Ishimoto

SHIONOGI & CO., LTD. Integrated Disease Care Division Medical Affairs Department

yoshikazu.ishimoto@shionogi.co.jp06-6209-7412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026